Dr Anne Blackwood


As well as being Chair for Medovate, Anne is CEO of Health Enterprise East – the leading NHS innovation hub. Anne has been actively involved in knowledge transfer and intellectual property management in the life sciences for over 20 years.

Prior to Health Enterprise East, Anne worked for Cambridge Enterprise, the technology transfer office of the University of Cambridge, where she focused primarily on technologies from the biological and chemical sciences and was involved in all aspects of technology commercialisation.

Anne holds a PhD in chemistry from Strathclyde University and is a non-executive director of Ablatus Therapeutics Limited and the Medtech Accelerator Limited.